Clinical Trials Browser

Phase 2 × pasireotide × Gastrointestinal × Clear all

NCT01639352 2017-07-12

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

20 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00958841 2016-07-26

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Phase 2 Terminated

118 enrolled 11 charts

EndocrineGastrointestinal

ACTH Syndrome, Ectopic, Nelson Syndrome, Pancreatic Neoplasms, Pituitary Neoplasms, Neuroectodermal Tumors, Primitive